Statistics

Total Visits

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup78

Select a period of time:

Number of views in the range

Views
FCGR2A/CD32A and FCGR3A/CD16A variants and EULAR response to tumor necrosis factor-alpha blockers in psoriatic arthritis: A longitudinal study with 6 months of followup22

Views

Views
July 202513
August 20250
September 20250
October 20252
November 20251
December 20256
January 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil6
United Kingdom5
Egypt1
France1
Mexico1
 

Top cities views

Views
Araras1
Ashburn1
Cairo1
Carapicuíba1
Conyers1
Gulf Breeze1
Juiz de Fora1
Neuilly-Plaisance1
Pittsburgh1
Portland1